Document is current

Any future updates will be listed below

2. Durable Efficacy of Alefacept in New-Onset Type 1 Diabetes: Evidence for Lasting Modulation of Effector and Regulatory T Cells (231-OR)

Crossref DOI link: https://doi.org/10.1007/s12467-015-0023-z

Published Online: 2015-09-21

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark